This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Asthma or COPD
and you are
over 60
years old
The phase for this study is not defined.
Show me locations

The purpose

This is a randomized, multi-center, active-controlled, repeated measures design study in male and female patients 60 years of age and older with persistent asthma or COPD. Study will be conducted in 4 Italian University/Hospital Centers: Ferrara, Parma, Cassano delle Murge (Ba), Tradate. The primary efficacy parameter of the study is inhaler device usability (expressed as total number of repeated attempts required to achieve optimal use).

Provided treatments

  • Device: Spiromax (budesonide/formoterol)
  • Device: Turbohaler (budesonide/formoterol)
  • Device: Diskus(50mcg salmeterol &250/500 mcg fluticasone propionate)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02757209. The sponsor of the trial is Consorzio Futuro in Ricerca and it is looking for 84 volunteers for the current phase.
Official trial title:
STUDY NUMBER: PMC-101-APT Usability and Adherence of Spiromax® Inhaler Device, Turbohaler® and Diskus® Inhaler Devices for Fixed Combination of Corticosteroid/Long-acting beta2- Agonist, in Adults With Asthma or COPD